With the advent of potential disease modifying agents, early identification and diagnosis of individuals with Mild Cognitive Impairment (MCI) and Alzheimer disease is critical. Unfortunately, primary care doctors do not identify these patients for roughly 3.5 years after symptoms are obvious to other. Alzheimer disease (AD) is a progressive neurodegenerative disease with an insidious onset that is difficult to distinguish from normal aging especially in its earliest stages. It typically begins with a subtle impairment of memory that evolves into the amnestic form of mild cognitive impairment (aMCI).
Alzheimer Disease & Parkinsonism is a journal published under the Medical journals, providing best open access articles in the related fields. Open access journal articles are essentially peer-reviewed and available for access through the directory of Open Access journals.
Last date updated on July, 2014
